CN101014720B - 用于乳腺癌的预后的方法和试剂盒 - Google Patents
用于乳腺癌的预后的方法和试剂盒 Download PDFInfo
- Publication number
- CN101014720B CN101014720B CN2005800303728A CN200580030372A CN101014720B CN 101014720 B CN101014720 B CN 101014720B CN 2005800303728 A CN2005800303728 A CN 2005800303728A CN 200580030372 A CN200580030372 A CN 200580030372A CN 101014720 B CN101014720 B CN 101014720B
- Authority
- CN
- China
- Prior art keywords
- mark
- expression
- group
- gene
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
PTHrP | |||
Pttg1 | * | ||
Rho-C | * | ||
Rho-G | |||
S100A4 | |||
Scotin | * | ||
SDF1 | * | ||
SEMP1 | * | ||
SPARC | |||
SPF45 | * | ||
SST1 | * | ||
ST15 | * | ||
TACC2 | * | ||
TBD10 | * | ||
TCF2 | * | ||
TCF3 | |||
TEM6 | * | ||
TEM7R | * | ||
VECAD | |||
Vilip | |||
Wave2 | |||
ZO-3 | * |
RhoC | * | ||
Rock1 | * | ||
S100A4 | |||
SDF1 | * | ||
SEMP1 | |||
SST1 | * | ||
ST15 | * | ||
TACC2 | |||
TEM6 | * | ||
TEM7R | * | ||
遍在蛋白 | |||
WISP2 |
Claims (12)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0417740A GB0417740D0 (en) | 2004-08-10 | 2004-08-10 | Methods and kit for the prognosis of breast cancer |
GB0417740.8 | 2004-08-10 | ||
GB0426777A GB0426777D0 (en) | 2004-12-07 | 2004-12-07 | Methods and kit for the prognosis of breast cancer |
GB0426777.9 | 2004-12-07 | ||
PCT/GB2005/002971 WO2006016110A1 (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110315370.0A Division CN102443627B (zh) | 2004-08-10 | 2005-07-27 | 用于乳腺癌的预后的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101014720A CN101014720A (zh) | 2007-08-08 |
CN101014720B true CN101014720B (zh) | 2012-10-03 |
Family
ID=32982775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800303728A Expired - Fee Related CN101014720B (zh) | 2004-08-10 | 2005-07-27 | 用于乳腺癌的预后的方法和试剂盒 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101014720B (zh) |
GB (1) | GB0417740D0 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623664B (zh) | 2008-11-11 | 2018-08-07 | 密歇根大学董事会 | 抗cxcr1组合物和方法 |
WO2010129934A2 (en) | 2009-05-07 | 2010-11-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
WO2010138839A2 (en) | 2009-05-28 | 2010-12-02 | Abraxis Bioscience, Llc | Use of 2 anti-sparc antibodies to predict response to chemotherapy |
EP2478362B1 (en) * | 2009-09-18 | 2016-05-11 | Abraxis BioScience, LLC | Use of the sparc microenvironment signature in the treatment of cancer |
AU2011261240A1 (en) | 2010-06-03 | 2013-01-10 | Abraxis Bioscience, Llc | Use of the SPARC microenvironment signature in the treatment of cancer |
CN102183655B (zh) * | 2011-01-24 | 2014-06-11 | 中国人民解放军军事医学科学院生物医学分析中心 | 用于乳腺癌内分泌治疗预后判断的新的分子标志物cuedc2蛋白质 |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
CN105628919A (zh) * | 2014-10-30 | 2016-06-01 | 上海市第十人民医院 | Cd166作为肝癌诊断血清标志物的应用及其试剂盒 |
WO2016073768A1 (en) | 2014-11-05 | 2016-05-12 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
EP3265588A4 (en) * | 2015-03-04 | 2018-10-10 | Veracyte, Inc. | Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information |
CN106337081B (zh) * | 2016-02-02 | 2020-01-21 | 中国医学科学院肿瘤医院 | FABP4基因的SNP位点rs1054135与三阴型乳腺癌预后的相关性 |
GB201608000D0 (en) * | 2016-05-06 | 2016-06-22 | Oxford Biodynamics Ltd | Chromosome detection |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
CN107446023B (zh) * | 2017-09-07 | 2020-03-27 | 华中科技大学同济医学院附属协和医院 | 一种可拮抗HuR蛋白RNA结合活性的多肽HIP-13及其应用 |
CN109182479A (zh) * | 2018-07-27 | 2019-01-11 | 广州医科大学附属第医院 | 一种实时荧光定量pcr通用型荧光探针及其应用 |
-
2004
- 2004-08-10 GB GB0417740A patent/GB0417740D0/en not_active Ceased
-
2005
- 2005-07-27 CN CN2005800303728A patent/CN101014720B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
Schwirzke Marina等.Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines.Anticancer Research.2001,211771-1776. * |
Also Published As
Publication number | Publication date |
---|---|
GB0417740D0 (en) | 2004-09-08 |
CN101014720A (zh) | 2007-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101014720B (zh) | 用于乳腺癌的预后的方法和试剂盒 | |
CN102443627B (zh) | 用于乳腺癌的预后的试剂盒 | |
EP2619321B1 (en) | Biomarkers for differentiating melanoma from benign nevus in the skin | |
JP6743056B2 (ja) | 前立腺がん予後判定の方法 | |
JP2016189781A (ja) | 内分泌治療下における乳癌再発を予測するための方法 | |
KR20120065959A (ko) | 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 | |
AU2020202536B2 (en) | Methods For Predicting Risk Of Metastasis In Cutaneous Melanoma | |
MX2014009283A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
JP2013532482A (ja) | 遺伝子発現を用いた前立腺癌の予後を定量化する方法 | |
US10233502B2 (en) | Compositions for and methods of detecting, diagnosing, and prognosing thymic cancer | |
CN109402252A (zh) | 急性髓系白血病风险评估基因标志物及其应用 | |
KR102376220B1 (ko) | 전립선암에서 후기 임상적 종점을 평가하기 위한 알고리즘 및 방법 | |
TW201641693A (zh) | 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置 | |
CN110331207A (zh) | 肺腺癌生物标志物及相关应用 | |
EP3298172A1 (en) | Determining risk of prostate cancer recurrence | |
EP2083087A1 (en) | Method for determining tongue cancer | |
CN116926190A (zh) | 测量乳腺癌远端转移风险的预后标志物及其应用 | |
CN115216543A (zh) | 核酸探针或引子在制备用于评估乳癌复发与转移风险方法的试剂盒的应用 | |
CN116936086A (zh) | 乳腺癌远端转移风险预测基因模型的建构方法和风险预测方法 | |
CN117385034A (zh) | 标志物组合在制备预测肝癌患者预后治疗疗效产品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CARDIFF BIOLOGY CO., LTD. Free format text: FORMER OWNER: UNIV CARDIFF Effective date: 20080704 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080704 Address after: Cardiff, United Kingdom Applicant after: Cardiff Biologicals Ltd. Address before: Cardiff, United Kingdom Applicant before: University COLLEGE CARDIFF CONSULTANTS LIMITED |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD., (GB) Free format text: FORMER OWNER: CARDIFF BIOLOGICALS LTD. Effective date: 20150529 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150529 Address after: Cardiff, United Kingdom Patentee after: University COLLEGE CARDIFF CONSULTANTS LIMITED Address before: Cardiff, United Kingdom Patentee before: Cardiff Biologicals Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160226 Address after: 102600, Beijing Zhongguancun Daxing District science and Technology Park, Daxing pharmaceutical industry base, Tian Fu Street, No. 17 Patentee after: Beijing Yiling Pharmaceutical Technology Co.,Ltd. Address before: Cardiff, United Kingdom Patentee before: University COLLEGE CARDIFF CONSULTANTS LIMITED |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121003 |